Interplay between Solid Tumors and Tumor Microenvironment.
Seung-Jin Kim1,2, Dipendra Khadka3, Jae Ho Seo4,5
1Department of Biochemistry, College of Natural Sciences, and Kangwon Institute of Inclusive Technology, Kangwon National University, Chuncheon, South Korea.
Frontiers in Immunology
|June 16, 2022
Summary
Cancer cells adapt to harsh conditions by communicating with their surroundings. Understanding tumor-environment interactions is key to developing new cancer therapies.
Area of Science:
- Oncology
- Cell Biology
- Cancer Research
Background:
- Cancer research has evolved, focusing on tumor adaptation to adverse conditions like nutrient deprivation and immune attack.
- Tumor heterogeneity arises from varying microenvironments and cellular plasticity, impacting treatment outcomes.
- Recent studies explore how tumors interact with stromal cells, immune cells, and secreted molecules.
Purpose of the Study:
- To review how tumors adapt to unfavorable environments through communication with neighboring cells.
- To highlight the role of cellular plasticity in tumor heterogeneity and therapy response.
- To emphasize the importance of understanding tumor-environment interactions for developing novel cancer treatments.
Main Methods:
- Literature review of mechanistic studies on tumor adaptation and microenvironment communication.
- Analysis of research on genetic/non-genetic changes, metabolic alterations, and cell migration in tumors.
- Synthesis of findings on cellular plasticity driven by microenvironment signals and epigenetic modifications.
Main Results:
- Tumors adapt to stress through genetic/non-genetic changes, altered metabolism, and migration.
- Tumor heterogeneity is driven by microenvironment signals, leading to cellular plasticity.
- Communication between tumor cells and surrounding cells (stromal, immune) is crucial for survival and progression.
Conclusions:
- Understanding tumor adaptation and microenvironment communication is vital for cancer treatment.
- Targeting tumor-environment interactions offers potential for developing effective cancer therapies.
- Cellular plasticity and heterogeneity are key factors influenced by the tumor microenvironment.
Related Concept Videos
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Immunotherapy
656
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
656
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K


